« Previous
Next »
Journal of Vascular and Interventional Radiology
Volume 20, Issue 5
, Pages 606-613
, May 2009
Incorporating Cone-beam CT into the Treatment Planning for Yttrium-90 Radioembolization
References
- . The utility of DynaCT in neuroendovascular procedures. AJNR Am J Neuroradiol. 2006;27:330–332
- . Transjugular intrahepatic portosystemic shunt creation in a polycystic liver facilitated by hybrid crosssectional/angiographic imaging. J Vasc Interv Radiol. 2006;17:711–715
- Cone-beam CT with flat-detector digital angiography system: early experience in abdominal interventional procedures. Cardiovasc Intervent Radiol. 2006;29:1034–1038
- Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol. 2007;18:1500–1507
- Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol. 2007;18:1305–1309
- . Three-dimensional rotational angiography: introduction of an adjunctive tool for successful transarterial chemoembolization. J Vasc Interv Radiol. 2005;16:1241–1245
- Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics. 2005;25(suppl):S41–S55
- Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol. 2007;18:553–561
- Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007;68:13–23
- Angiographic considerations in patients undergoing liver directed therapy. J Vasc Interv Radiol. 2005;16:911–935
- Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization. J Vasc Interv Radiol. 2007;18:1508–1516
- . Patient dose from 3D rotational neurovascular studies. Br J Radiol. 2007;80:362–366
N.K. and L.V.H. have received research grants from Siemens (Erlangen, Germany); D.Y.S. serves as a paid consultant to MediGene (San Diego, California), Pain Therapeutics (San Francisco, California), and Jennerex Biotherapeutics (San Francisco, California). None of the other authors have identified a conflict of interest.
PII: S1051-0443(09)00060-8
doi: 10.1016/j.jvir.2009.01.021
© 2009 SIR. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular and Interventional Radiology
Volume 20, Issue 5
, Pages 606-613
, May 2009
